TIMI Risk Score (NSTEMI)
Guide therapeutic decisions in non-ST elevation MI.
Although not absolute, the TIMI risk score has been shown to be useful to guide therapeutic decisions.
Patients with a TIMI score ≥ 3 benefited from an early invasive strategy.
Patients with a TIMI score ≥ 4 benefited from enoxaparin (as opposed to unfractionated heparin) and the addition of a IIb:IIIa inhibitor (Tirofiban) to heparin.
Antman et al.
JAMA: the Journal of the American Medical Association 2000 August 16, 284 (7): 835-42
Cannon CP et al.
New England Journal of Medicine 2001 June 21, 344 (25): 1879-87
Morrow DA et al.
European Heart Journal 2002, 23 (3): 223-9
Marc S Sabatine et al.
American Heart Journal 2002, 143 (6): 966-70
The TIMI Risk Score (NSTEMI) calculator is created by QxMD.